CASP3 and cancer: Analysis of key PD biomarkers of DNA damage, RS (γH2AX), and apoptosis (c-Casp-3/7) further validated previously reported increases in RS in KRASG12C inhibitor–treated cancer cells while also demonstrating further upregulation in response to combination treatment.